Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net (loss) income	$ (1,773,204)	$ 5,938,279
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Gain on sale of building	0	(6,894,109)
Gain on debt extinguishment	0	(2,443,418)
Stock-based compensation	307,379	217,942
Depreciation and amortization	537,903	585,082
Changes in assets and liabilities:
Accounts receivable	(1,404,506)	(844,185)
Contract assets	(614,096)	(1,133,887)
Inventories	(908,753)	(341,905)
Tax receivable	715,599	0
Other current assets	(66,230)	491,764
Accounts payable	362,512	36,226
Accrued expenses	686,851	95,281
Contract liabilities	(172,532)	717,688
Total adjustments	(555,873)	(9,513,521)
Net cash used in operating activities	(2,329,077)	(3,575,242)
Cash flows from investing activities:
Net proceeds from sale of building	0	23,075,477
Net proceeds from sale of assets	10,000	0
Capitalized patents costs	(52,911)	0
Capital expenditures	(637,954)	(212,920)
Net cash (used in) provided by investing activities	(680,865)	22,862,557
Cash flows from financing activities:
Repayments of long-term debt	(1,765,508)	(9,540,246)
Net cash used in financing activities	(1,765,508)	(9,540,246)
Net (decrease) increase in cash and cash equivalents	(4,775,450)	9,747,069
Cash and cash equivalents at beginning of period	16,651,371	7,699,335
Cash and cash equivalents at end of period	11,875,921	17,446,404
Supplemental disclosure of cash flow information:
Income taxes paid	890	28,391
Interest paid	8.157	250,194
Non-cash investing and financing activities:
Loan obtained for new equipment	$ 432,000	$ 0